Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin

Strahlenther Onkol. 2016 Sep;192(9):672-4. doi: 10.1007/s00066-016-1016-6.
[Article in German]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Astrocytoma / mortality*
  • Astrocytoma / pathology
  • Astrocytoma / therapy*
  • Brain Neoplasms / mortality*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy*
  • Chemoradiotherapy / mortality*
  • Chemoradiotherapy / statistics & numerical data*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Lomustine / administration & dosage
  • Male
  • Neoplasm Grading
  • Prevalence
  • Procarbazine / administration & dosage
  • Prognosis
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome
  • United States / epidemiology
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • Procarbazine
  • Vincristine
  • Lomustine